Endovenous ablation of the greater saphenous vein has nowadays the same outcome as open crossectomy and stripping. The two most performed techniques for endovenous ablation are the endovenous laser ablation and the radiofrequency ablation. According to the trial of Rasmussen, they are equivalent for occlusion but the lower laser wave lengths resulted in more pain and paresthesia. The newer wave length of 1470 nm showed lesser side effects in observational studies. The aim of this study is to compare radiofrequency ablation with the VNUS closure fast ® with laser ablation with a 1470 nm wave length in combination with a new fiber, the Tulip fiber ®. This fiber has the shape of a tulip at his tip which avoids point necroses of the vessel wall and on consequence results in lesser side effects from wall perforations such as pain, haematoma,…
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
280
Laser ablation with a wavelength of 1470 nanometers will be performed, in combination with a new sort of fiber: the tulip tip fiber.
Radiofrequent ablation will be performed in combination with the catheter 'VNUS closure fast'.
Ghent University Hospital
Ghent, Belgium
University Hospital Leuven
Leuven, Belgium
Sint-Andriesziekenhuis Tielt
Tielt, Belgium
Closure of the greater saphenous vein at 12 months.
Closure of the greater saphenous vein will be measured by venous duplex, Kabnick score and modified Gelev score. This will be performed after 5 days, 1 month, 6 months and 12 months.
Time frame: 12 months after procedure
Pain.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 5 days
Pain.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 14 days
Pain.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 1 month
Pain.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 6 months
Pain.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 1 year.
Patient satisfaction rate.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 5 days
Patient satisfaction rate.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 14 days.
Patient satisfaction rate.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 1 month
Pain satisfaction rate.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 6 months
Patient satisfaction rate.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 1 year.
Incapacity to work.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: after 5 days
Incapacity to work.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 14 days
Incapacity to work.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 1 month
Incapacity to work.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 6 months
Incapacity to work.
This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.
Time frame: After 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.